TITLE

Fat In, Fat Out

AUTHOR(S)
Bedevian, Rima
PUB. DATE
August 2007
SOURCE
Plastic Surgery Products;Aug2007, p12
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article highlights the results of a study on neuropeptide Y (NPY). The study found that the NPY receptor can prevent the development of fat which can revolutionize plastic surgery and the treatment of diseases that are associated with obesity. The study also shows that stress has a direct effect on fat accumulation, body weight and metabolism.
ACCESSION #
26074639

 

Related Articles

  • Y2Y4 Receptor Double Knockout Protects Against Obesity Due to a High-Fat Diet or Y1 Receptor Deficiency in Mice. Sainsbury, Amanda; Bergen, Hugo T.; Boey, Dana; Bamming, Darja; Cooney, Gregory J.; Shu Lin; Couzens, Michelle; Stroth, Nikolas; Lee, Nicola J.; Lindner, Diana; Singewald, Nicolas; Karl, Tim; Duffy, Liesl; Enriquez, Ronaldo; Slack, Katy; Sperk, Günther; Herzog, Herbert // Diabetes;Jan2006, Vol. 55 Issue 1, p19 

    Neuropeptide Y receptors are critical regulators of energy homeostasis, but the functional interactions and relative contributions of Y receptors and the environment in this process are unknown. We measured the effects of an ad libitum diet of normal or high-fat food on energy balance in mice...

  • Interaction between Leptin and Neuropeptide Y on in vivo Growth Hormone Secretion. Carro, Eva; Seoane, Luisa M.; Señaris, Rosa; Considine, Robert V.; Casanueva, Felipe F.; Dieguez, Carlos // Neuroendocrinology;1998, Vol. 68 Issue 3, p187 

    Leptin, the product of the ob gene, is a recently discovered hormone secreted by adipocytes that regulates food intake and energy expenditure. Leptin has recently been shown to play a stimulatory role on GH secretion. The aim of the present study was to investigate whether leptin regulation of...

  • New research reveals brain chemical, not unhealthy lifestyle, may be cause of obesity.  // Jet;12/30/96 - 01/06/97, Vol. 91 Issue 7, p33 

    Offers the results of a study conducted on the cause of obesity. Speculation on the role of a brain chemical known as neuropeptide Y or NPY; Comments from Jay Erickson, a Howard Hughes Institute researcher at the University of Washington about the possibility of flawed OB, or fat gene.

  • CORRESPONDENCE.  // British Medical Journal (Clinical Research Edition);6/27/1987, Vol. 294 Issue 6588, p1686 

    Comments on several topics related to medicine in Great Britain. Additional of neuropeptide Y and galanin on the list of peptides possible endocrine causes of obesity; Proposition of a confidential inquiry for the deaths of women from cancer of cervix; Evaluation of the use of hemoglobinometry...

  • Preface[Hot Topic: Medicinal Strategies in the Treatment of Obesity (Guest Editor: Akio Inui)]. Inui, Akio // Current Medicinal Chemistry - Central Nervous System Agents;Sep2003, Vol. 3 Issue 3, p1 

    INTRODUCTION An insidious increase in features of the metabolic syndrome such as obesity, insulin resistance and dyslipidemia, has led to a worldwide epidemic of type 2 diabetes mellitus[1]. This heterogenous disorder accounts for 90-95% of all diabetes and afflicts an estimated 6% of the adult...

  • The skinny on neurotrophins. Wisse, Brent E; Schwartz, Michael W // Nature Neuroscience;Jul2003, Vol. 6 Issue 7, p655 

    Obesity and its comorbid illnesses are a leading world health concern for which few effective treatments exist. Obesity is increasingly viewed as a disorder of energy homeostasis, a regulatory process that involves hormones such as insulin and leptin that circulate at levels proportionate to...

  • Peripheral-Specific Y2 Receptor Knockdown Protects Mice From High-Fat Diet-Induced Obesity. Shi, Yan-chuan; Lin, Shu; Castillo, Lesley; Aljanova, Aygul; Enriquez, Ronaldo F.; Nguyen, Amy D.; Baldock, Paul A.; Zhang, Lei; Bijker, Martijn S.; Macia, Laurence; Yulyaningsih, Ernie; Zhang, Hui; Lau, Jackie; Sainsbury, Amanda; Herzog, Herbert // Obesity (19307381);Nov2011, Vol. 19 Issue 11, p2137 

    Y2 receptors, particularly those in the brain, have been implicated in neuropeptide Y (NPY)-mediated effects on energy homeostasis and bone mass. Recent evidence also indicates a role for Y2 receptors in peripheral tissues in this process by promoting adipose tissue accretion; however their...

  • Chronic central melanocortin-4 receptor antagonism and central neuropeptide-Y infusion in rats produce increased adiposity by divergent pathways. Baran, Katherine; Preston, Elaine; Wilks, Donna; Cooney, Gregory J.; Kraegen, Edward W.; Sainsbury, Amanda // Diabetes;Jan2002, Vol. 51 Issue 1, p152 

    Increased hypothalamic neuropeptide-Y (NPY) action and disruption of the melanocortin (MC)-4 receptor both result in hyperphagia and obesity. To determine whether similar hormonal and metabolic mechanisms are involved in these two obesity syndromes, we investigated the time course of effects...

  • Prime time for neuropeptide Y. Howlett, Rory // Nature;7/11/1996, Vol. 382 Issue 6587, p113 

    Reports that attention has switched to neuropeptide Y (NPY), a hormone known to increase food intake when injected into the central nervous system. Role of NPY in the feeding pathway.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics